Influence of Keratinized Mucosa on Dental Implants With Mucositis
1 other identifier
interventional
38
1 country
1
Brief Summary
Introduction: It seems that some local and systemic factors can be associated with an increased incidence of peri-implant diseases. Predisposing to an increase inflammatory response when plaque is present. There is still controversy on which factors can be considered as risk indicators. One of them is the keratinized mucosa width (KM), that seems to facilitate plaque control around implants. Objectives: Assess the relationship between keratinized mucosa and the recurrence of mucositis, comparing bleeding on probing (BOP) in implants with mucositis for 24 weeks after implant disinfection therapy, the control group is defined by having KM ≥ 2 mm and the test group KM \< 2 mm. Material and methods: 38 patients presenting one single implant each with a single screw retained crown loaded for at least 1 year. Periodontal maintenance therapy will be performed and oral hygiene instruction will be delivered. Follow up visits will be after 8, 12 and 24 weeks in which the following parameters will be registered: Keratinized Mucosa width, Attached mucosa, Gingival Index, Vestibule Depth, Mucosa Thickness. Probing Pocket Depth, Recession, modified Plaque Index, Bleeding on Probing, modified Bleeding Index. Also a microbiologic test will be taken in the implant sulcus before the periodontal maintenance therapy and at 24 weeks. A multilevel statistical analysis will be conducted comparing the control and the test group, adjusting for the correlation among multiple observations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 30, 2021
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2022
CompletedAugust 9, 2022
August 1, 2022
1.6 years
April 30, 2021
August 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Bleeding on probing
The main objective of the study is to evaluate the association between MQ and recurrence of mucositis, comparing the bleeding index on probing (BoP) in implants that have mucositis, in a control group characterized by 2 mm or more of MQ and a test group characterized by less than 2 mm of MQ over a 24-week period after peri-implant maintenance therapy.
24 weeks
Study Arms (2)
Keratinized Mucosa ≥ 2 mm
EXPERIMENTALSupportive periodontal therapy, in teeth by means of ultrasonic devices and manual curettes. In implants using the same devices but made of titanium. Oral hygiene instructions
Keratinized Mucosa < 2 mm
EXPERIMENTALSupportive periodontal therapy, in teeth by means of ultrasonic devices and manual curettes. In implants using the same devices but made of titanium. Oral hygiene instructions
Interventions
A complete professional prophylaxis session will be performed, which includes ultrasound debridement, scaling with curettes and dental polishing with a rubber cup. On the other hand, in implants affected by mucositis, supra and sub-gingival debridement will be performed using a combination of ultrasound with a titanium tip and titanium curettes. All patients will receive personalized hygiene instructions. Patients will be instructed to brush their implants twice daily using the modified Bass technique with a medium-hard manual toothbrush and low-abrasive toothpaste. In addition, they will be taught to use specific interproximal brushes. If access with an interdental brush is not possible, flossing will be indicated. Oral hygiene instructions will be reviewed at each visit.
Eligibility Criteria
You may qualify if:
- patients\> 18 years;
- smokers \<10 cigarettes / day;
- partially edentulous patients. The spaces must be associated with at least one adjacent mesial and one distal tooth;
- presence of bleeding and / or suppuration on probing, erythema and inflammation;
- absence of radiographic bone loss around implant distance (\<2mm from expected radiographic marginal bone level);
- individual dental implants rehabilitated for more than a year;
- screw-retained restorations on implants;
- absence of active periodontal disease;
- who have not taken systemic antibiotics in the last 3 months;
- adequate oral hygiene motivation and collaboration defined as plaque index \<25%
You may not qualify if:
- totally edentulous patients;
- uncontrolled systemic diseases;
- diseases of the mucosa (erosive lichen planus, etc.);
- taking medications that may interfere with periodontal health or healing; (corticosteroids, calcium channel antagonists, antiepileptic drugs, immunosuppressants, etc.)
- pregnant or lactating patients;
- cemented implant restorations;
- restorations on implants over contoured that cannot be corrected.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
International University of Catalunya
Barcelona, 08172, Spain
Related Publications (1)
Blasi G, Chierico F, Amerio E, Alvarez G, Isabal S, Arredondo A, Blanc V, Nart J, Monje A. Influence of keratinized mucosa width on the resolution of peri-implant mucositis: A prospective cohort study. Clin Implant Dent Relat Res. 2024 Jun;26(3):581-591. doi: 10.1111/cid.13317. Epub 2024 Mar 1.
PMID: 38426741DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jose Nart, DDS PhD
Universitat Internacional de Catalunya
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Instructor
Study Record Dates
First Submitted
April 30, 2021
First Posted
May 5, 2021
Study Start
September 1, 2020
Primary Completion
April 25, 2022
Study Completion
April 25, 2022
Last Updated
August 9, 2022
Record last verified: 2022-08